Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015
Abstract
Authors
M Prada C Bertozzi B Proietti D Urbinati